Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 208 participants.

Also called NCT06096246

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 208 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06096246
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06096246. Randomized; double masking; primary purpose treatment. Start 2024-07-26 (actual); primary completion 2027-07-26 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)
Acronym
ORBICA-AF
Condition
Persistent Atrial Fibrillation
Condition
Cardiac Arrhythmia
Intervention (Procedure)
Pulmonary vein isolation
Intervention (Procedure)
DC Cardioversion
Intervention (Device)
Implantable loop recorder
Intervention (Procedure)
Femoral sheath insertion
Lead sponsor
Barts & The London NHS Trust (class: other)

Record details

Record id
cardio:ct-nct06096246
Content hash
eca12c648236f34ae4cfd99975e3fa85ef83556e0f6df2531af3c4040557978e